Serotonin metabolism in migraine

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Migraine is a complex neurological disorder often associated with alterations in neurotransmitter systems.
• Systemic serotonin (5-HT) metabolism plays a role in various physiological processes, and its dysregulation is implicated in migraine pathophysiology.

Purpose of the Study:

• To investigate the systemic serotonin (5-HT) metabolism in patients with classic and common migraine.
• To compare concentrations of 5-HT, its precursors (tryptophan, 5-hydroxytryptophan), and its metabolite (5-hydroxyindoleacetic acid) in migraineurs and controls.

Main Methods:

• Measured platelet and plasma concentrations of 5-HT, tryptophan, 5-hydroxytryptophan, and 5-hydroxyindoleacetic acid (5-HIAA).
• Assessed platelet enzyme activities, including monoamine oxidase and phenolsulfotransferase, in migraineurs (classic and common) and controls.
• Collected samples both between and during migraine attacks.

Main Results:

• Between attacks, migraineurs exhibited lower plasma 5-HT and higher 5-HIAA levels compared to controls.
• During migraine attacks, plasma 5-HT levels increased, while 5-HIAA concentrations and platelet enzyme activities decreased.
• Platelet 5-HT reduction was observed only in common migraine attacks, not classic ones.

Conclusions:

• Systemic serotonin (5-HT) metabolism appears enhanced in migraineurs during headache-free periods, with a transient decrease during attacks, possibly due to reduced enzymatic degradation.
• Platelet behavior during migraine attacks varies between classic and common types.
• The rise in plasma 5-HT during attacks is not solely attributable to platelet 5-HT release.